CTRI Number |
CTRI/2022/10/046583 [Registered on: 18/10/2022] Trial Registered Prospectively |
Last Modified On: |
18/10/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Biological Ayurveda |
Study Design |
Single Arm Study |
Public Title of Study
|
To study efficacy of 5ml castor oil with 50ml dry ginger decoction in the management of lower back pain with special reference to Chakradatta |
Scientific Title of Study
|
Randomised clinical trial to study efficacy of Eranda Sneha(5ml)with Shunthi Kwatha(50ml) in the management of Katishoola with special reference to Chakradatta. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Simaran Gani Mulla |
Designation |
M.D. Scholar Ayurveda Samhita And Siddhant |
Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Pune |
Address |
Department of Ayurveda Samhita and Siddhant, Sane
Guruji Arogya Kendra, Malwadi road Hadapsar Pune
Pune MAHARASHTRA 411028 India |
Phone |
9021059794 |
Fax |
|
Email |
simaranm1@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Nilesh Kulkarni |
Designation |
Professor |
Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Pune |
Address |
Department of Ayurveda Samhita and Siddhant, Sane Guruji Arogya Kendra, Malwadi road Hadapsar Pune
Pune MAHARASHTRA 411028 India |
Phone |
8805335512 |
Fax |
|
Email |
prof.dr.nileshkulkarni@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Simaran Gani Mulla |
Designation |
M.D. Scholar Ayurveda Samhita And Siddhant |
Affiliation |
MAMs Sumatibhai Shah Ayurved Mahavidyalaya, Pune |
Address |
Department of Ayurveda Samhita and Siddhant, Sane Guruji Arogya Kendra, Malwadi road Hadapsar Pune
Pune MAHARASHTRA 411028 India |
Phone |
9021059794 |
Fax |
|
Email |
simaranm1@gmail.com |
|
Source of Monetary or Material Support
|
Department of Ayurved Samhita and Siddhanta, Sane Guruji Arogya Kendra, Malwadi Road Hadapsar Pune |
|
Primary Sponsor
|
Name |
Sane Guruji Arogya Kendra |
Address |
Department of Ayurveda Samhita and Siddhant, Sane Guruji Arogya Kendra, Malwadi road Hadapsar Pune |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Simaran Gani Mulla |
Sane Guruji Arogya Kendra |
Department of Ayurveda Samhita and Siddhanta ,Attacted OPD of Sane Guruji Arogya Kendra,Malwadi Road Hadapsar , pune Pune MAHARASHTRA |
9021059794
simaranm1@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institution Ethical committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: M958||Other specified acquired deformities of musculoskeletal system, (2) ICD-10 Condition:M958||Other specified acquired deformities of musculoskeletal system. Ayurveda Condition: VATAPRAKOPAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: Eranda sneha , Reference: Chakradatta , Route: Oral, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Shunthi kwatha ), Additional Information: - |
|
|
Inclusion Criteria
|
Age From |
30.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1. Patients having symptom of Katishool more than 7 days and less than 3 months.
2. Avarodha Janya Samprapti.
3. No specific and major pathology of degenerative changes
4. Gender - Male and Female
|
|
ExclusionCriteria |
Details |
1.Taking NSAIDs
2.Patient having inborn structural deformities.
3. Diagnosed with Fracture of Lumbar Spine etc. and needs surgical intervention
4.Patients having other joint deformities or diseases which are not related to Katishoola.
5. Katishoola is associated with known case of Cardiac disease, Pulmonary TB, Pregnancy, Paralysis, Neurological disorder, HIV or any other relevant pathology.
|
|
Method of Generating Random Sequence
|
Random Number Table |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Primary outcome is assessment of Katishoola with pain scale |
intervention for consecutive 7 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
Comparative analysis of pain and functional improvement
|
Day 1 and Day 7 2visit |
|
Target Sample Size
|
Total Sample Size="35" Sample Size from India="35"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
31/10/2022 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
31/10/2022 |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
Not Yet |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
The study will be done on the patients selected on the basis on inclusion criteria, The initial assessment will be done on 1st day. Then the treatment will be started (Erand sneha 5ml with sunthi kwatha 50ml before dinner for seven days. On 8th day follow up will be done. Result of 1st day assessment will be compared with 8th day assessment. Result will be drawn after discussion and conclusion based on statistical analysis |